Relay Therapeutics

Cambridge, United States

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

May 2026

Post-IPO Equity

Biotechnology Health Care Therapeutics

Top Investors

Perceptive AdvisorsForesite CapitalThird Rock VenturesGoogle VenturesS32

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Relay Therapeutics

Who are Relay Therapeutics's investors?

Relay Therapeutics's investors include Perceptive Advisors, Foresite Capital, Third Rock Ventures, Google Ventures, S32.

Where is Relay Therapeutics headquartered?

Relay Therapeutics is headquartered in Cambridge, United States.

What does Relay Therapeutics do?

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

What stage is Relay Therapeutics at?

Relay Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 20, 2026.

MLA

"Relay Therapeutics — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/relay-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Relay Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/relay-therapeutics

Wikipedia (cite web)

{{cite web |title=Relay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/relay-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 20, 2026.

Similar Companies in Biotechnology